Scotts Miracle-Gro (SMG) Sees 2% Decline in FY11 Sales, EPS to Miss Views
Tweet
Share
E-mailGet Alerts SMG Hot Sheet
Price: $61.01 +0.89%
Financial Fact:
Interest expense: 13.3M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Interest expense: 13.3M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
The Scotts Miracle-Gro Company (NYSE: SMG), expects to report a 2 percent decline in sales for fiscal 2011 when it issues its full-year financial results on November 8. The sales shortfall, coupled with associated gross margin pressure, will likely result in adjusted net earnings in a range of approximately $2.70 to $2.75 per share.
The Street is currently looking for EPS of $2.98.
The reduced outlook stems primarily from an unexpected year-over-year decline in consumer purchases in the U.S. during September.
The Street is currently looking for EPS of $2.98.
The reduced outlook stems primarily from an unexpected year-over-year decline in consumer purchases in the U.S. during September.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- BMO starts chip stocks coverage: Here are its preferred picks
Create E-mail Alert Related Categories
Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
